Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation

Elizabeth B. Staab, Jason Weigel, Fengxia Xiao, Nandakumar Madayiputhiya, Todd A Wyatt, Sandra M. Wells

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

There is increasing evidence that the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethyl-arginine (ADMA) is involved in the pathogenesis of chronic lung diseases. One important regulator of this molecule is the ADMA-metabolizing enzyme dimethyl-arginine dimethyl-aminohydrolase (DDAH). The objective of this study was to determine whether perturbation of the ADMA-DDAH pathway contributes to lung inflammation following exposure to cigarette smoke (CS). For these studies, wild-type and DDAH transgenic mice were sham or CS-exposed. Serum ADMA levels were determined by mass spectrometry. ADMA content and DDAH expression were also visualized in mouse lung tissue by immunohistochemistry. DDAH expression was determined by real-time quantitative PCR (qPCR). Inflammation was assessed by H&E staining and analyses of total cell counts and fluid tumor necrosis factor (TNF)-α levels (using ELISA) in lung lavage fluid. NF-κB binding activity in mouse lung epithelial (LA-4) cells was assessed by a transcription factor-binding assay. The results indicated that the concentration of serum ADMA was increased following exposure to CS, and this corresponded with increased ADMA content in bronchial epithelial cells in lung tissue. Total lung DDAH expression was significantly decreased in lung tissue and cultured LA-4 cells following CS exposure. Addition of exogenous ADMA increased CSE-mediated NF-κB binding activity and TNFα production in LA-4 cells more than 2-fold compared to that in CSE-exposed controls. CS-mediated lung inflammation was significantly attenuated in DDAH transgenic mice compared to in wild-type controls. These findings demonstrated that lung ADMA metabolism was altered in mice following CS exposure and suggested that ADMA played a role in CS-mediated inflammation through increasing the presence of inflammatory mediators in lung epithelial cells.

Original languageEnglish (US)
Pages (from-to)273-282
Number of pages10
JournalJournal of Immunotoxicology
Volume12
Issue number3
DOIs
StatePublished - Jul 1 2015

Fingerprint

Metabolism
Smoke
Tobacco Products
Arginine
Pneumonia
Aminohydrolases
Lung
Tissue
Transgenic Mice
Tumor Necrosis Factor-alpha
Epithelial Cells
Inflammation
Pulmonary diseases
Fluids
Bronchoalveolar Lavage Fluid
Serum
Nitric Oxide Synthase
Lung Diseases
Mass spectrometry
Real-Time Polymerase Chain Reaction

Keywords

  • Airway
  • Dimethyl-arginine dimethylaminohydrolase
  • Nuclear factor-κB

ASJC Scopus subject areas

  • Immunology
  • Toxicology

Cite this

Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation. / Staab, Elizabeth B.; Weigel, Jason; Xiao, Fengxia; Madayiputhiya, Nandakumar; Wyatt, Todd A; Wells, Sandra M.

In: Journal of Immunotoxicology, Vol. 12, No. 3, 01.07.2015, p. 273-282.

Research output: Contribution to journalArticle

Staab, Elizabeth B. ; Weigel, Jason ; Xiao, Fengxia ; Madayiputhiya, Nandakumar ; Wyatt, Todd A ; Wells, Sandra M. / Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation. In: Journal of Immunotoxicology. 2015 ; Vol. 12, No. 3. pp. 273-282.
@article{57c97090f592430ba84632bf63f96f08,
title = "Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation",
abstract = "There is increasing evidence that the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethyl-arginine (ADMA) is involved in the pathogenesis of chronic lung diseases. One important regulator of this molecule is the ADMA-metabolizing enzyme dimethyl-arginine dimethyl-aminohydrolase (DDAH). The objective of this study was to determine whether perturbation of the ADMA-DDAH pathway contributes to lung inflammation following exposure to cigarette smoke (CS). For these studies, wild-type and DDAH transgenic mice were sham or CS-exposed. Serum ADMA levels were determined by mass spectrometry. ADMA content and DDAH expression were also visualized in mouse lung tissue by immunohistochemistry. DDAH expression was determined by real-time quantitative PCR (qPCR). Inflammation was assessed by H&E staining and analyses of total cell counts and fluid tumor necrosis factor (TNF)-α levels (using ELISA) in lung lavage fluid. NF-κB binding activity in mouse lung epithelial (LA-4) cells was assessed by a transcription factor-binding assay. The results indicated that the concentration of serum ADMA was increased following exposure to CS, and this corresponded with increased ADMA content in bronchial epithelial cells in lung tissue. Total lung DDAH expression was significantly decreased in lung tissue and cultured LA-4 cells following CS exposure. Addition of exogenous ADMA increased CSE-mediated NF-κB binding activity and TNFα production in LA-4 cells more than 2-fold compared to that in CSE-exposed controls. CS-mediated lung inflammation was significantly attenuated in DDAH transgenic mice compared to in wild-type controls. These findings demonstrated that lung ADMA metabolism was altered in mice following CS exposure and suggested that ADMA played a role in CS-mediated inflammation through increasing the presence of inflammatory mediators in lung epithelial cells.",
keywords = "Airway, Dimethyl-arginine dimethylaminohydrolase, Nuclear factor-κB",
author = "Staab, {Elizabeth B.} and Jason Weigel and Fengxia Xiao and Nandakumar Madayiputhiya and Wyatt, {Todd A} and Wells, {Sandra M.}",
year = "2015",
month = "7",
day = "1",
doi = "10.3109/1547691X.2014.961619",
language = "English (US)",
volume = "12",
pages = "273--282",
journal = "Journal of Immunotoxicology",
issn = "1547-691X",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation

AU - Staab, Elizabeth B.

AU - Weigel, Jason

AU - Xiao, Fengxia

AU - Madayiputhiya, Nandakumar

AU - Wyatt, Todd A

AU - Wells, Sandra M.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - There is increasing evidence that the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethyl-arginine (ADMA) is involved in the pathogenesis of chronic lung diseases. One important regulator of this molecule is the ADMA-metabolizing enzyme dimethyl-arginine dimethyl-aminohydrolase (DDAH). The objective of this study was to determine whether perturbation of the ADMA-DDAH pathway contributes to lung inflammation following exposure to cigarette smoke (CS). For these studies, wild-type and DDAH transgenic mice were sham or CS-exposed. Serum ADMA levels were determined by mass spectrometry. ADMA content and DDAH expression were also visualized in mouse lung tissue by immunohistochemistry. DDAH expression was determined by real-time quantitative PCR (qPCR). Inflammation was assessed by H&E staining and analyses of total cell counts and fluid tumor necrosis factor (TNF)-α levels (using ELISA) in lung lavage fluid. NF-κB binding activity in mouse lung epithelial (LA-4) cells was assessed by a transcription factor-binding assay. The results indicated that the concentration of serum ADMA was increased following exposure to CS, and this corresponded with increased ADMA content in bronchial epithelial cells in lung tissue. Total lung DDAH expression was significantly decreased in lung tissue and cultured LA-4 cells following CS exposure. Addition of exogenous ADMA increased CSE-mediated NF-κB binding activity and TNFα production in LA-4 cells more than 2-fold compared to that in CSE-exposed controls. CS-mediated lung inflammation was significantly attenuated in DDAH transgenic mice compared to in wild-type controls. These findings demonstrated that lung ADMA metabolism was altered in mice following CS exposure and suggested that ADMA played a role in CS-mediated inflammation through increasing the presence of inflammatory mediators in lung epithelial cells.

AB - There is increasing evidence that the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethyl-arginine (ADMA) is involved in the pathogenesis of chronic lung diseases. One important regulator of this molecule is the ADMA-metabolizing enzyme dimethyl-arginine dimethyl-aminohydrolase (DDAH). The objective of this study was to determine whether perturbation of the ADMA-DDAH pathway contributes to lung inflammation following exposure to cigarette smoke (CS). For these studies, wild-type and DDAH transgenic mice were sham or CS-exposed. Serum ADMA levels were determined by mass spectrometry. ADMA content and DDAH expression were also visualized in mouse lung tissue by immunohistochemistry. DDAH expression was determined by real-time quantitative PCR (qPCR). Inflammation was assessed by H&E staining and analyses of total cell counts and fluid tumor necrosis factor (TNF)-α levels (using ELISA) in lung lavage fluid. NF-κB binding activity in mouse lung epithelial (LA-4) cells was assessed by a transcription factor-binding assay. The results indicated that the concentration of serum ADMA was increased following exposure to CS, and this corresponded with increased ADMA content in bronchial epithelial cells in lung tissue. Total lung DDAH expression was significantly decreased in lung tissue and cultured LA-4 cells following CS exposure. Addition of exogenous ADMA increased CSE-mediated NF-κB binding activity and TNFα production in LA-4 cells more than 2-fold compared to that in CSE-exposed controls. CS-mediated lung inflammation was significantly attenuated in DDAH transgenic mice compared to in wild-type controls. These findings demonstrated that lung ADMA metabolism was altered in mice following CS exposure and suggested that ADMA played a role in CS-mediated inflammation through increasing the presence of inflammatory mediators in lung epithelial cells.

KW - Airway

KW - Dimethyl-arginine dimethylaminohydrolase

KW - Nuclear factor-κB

UR - http://www.scopus.com/inward/record.url?scp=84928616747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928616747&partnerID=8YFLogxK

U2 - 10.3109/1547691X.2014.961619

DO - 10.3109/1547691X.2014.961619

M3 - Article

C2 - 25913572

AN - SCOPUS:84928616747

VL - 12

SP - 273

EP - 282

JO - Journal of Immunotoxicology

JF - Journal of Immunotoxicology

SN - 1547-691X

IS - 3

ER -